How does Bromocriptine impact pregnancy outcomes in women with prolactinomas and what considerations should be made during therapy?
Gaurav ChauhanContributor
How does Bromocriptine affect pregnancy outcomes in women with prolactinomas?
Share
Bromocriptine, used in prolactinoma patients, often restores fertility and enables pregnancy. It’s usually safe but should be monitored closely for any adverse effects on the mother or fetus.
1. Bromocriptine can improve fertility by lowering prolactin levels in women with prolactinomas, potentially normalizing menstrual cycles.
2. During bromocriptine therapy in pregnancy, it’s crucial to monitor for hypertension and to adjust dosages as needed to manage symptoms.
3. Bromocriptine is often discontinued once pregnancy is confirmed to lower the risk of adverse effects, though some cases may require continuation.
4. Regular endocrine evaluations during pregnancy while on bromocriptine ensure optimal management of prolactin levels and pituitary function.